Showing results (161-170 of 334) with videos related to
Sort By:
Pageof 34
Nature Communications|June 3, 2024
Anti-PD-1 cis-delivery of low-affinity IL-12 activates intratumoral CD8+T cells for systemic antitumor responsesZhuangzhi Zou, Jiao Shen, Diyuan Xue, et al.Nature Cancer|April 8, 2022
Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated antitumor immunityLongchao Liu, Jiahui Chen, Hongyi Zhang, et al.Scientific Reports|December 12, 2018
T cell-derived lymphotoxin limits Th1 response during HSV-1 infectionKaiting Yang, Yong Liang, Zhichen Sun, et al.The Journal of Experimental Medicine|September 27, 2022
An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis deliveryJiao Shen, Zhuangzhi Zou, Jingya Guo, et al.Nature Communications|October 8, 2021
Next generation of tumor-activating type I IFN enhances anti-tumor immune responses to overcome therapy resistanceXuezhi Cao, Yong Liang, Zhenxiang Hu, et al.Immunity|August 29, 2006
Recruitment and activation of naive T cells in the islets by lymphotoxin beta receptor-dependent tertiary lymphoid structureYoujin Lee, Robert K Chin, Peter Christiansen, et al.Nature|October 17, 2003
Positioning of follicular dendritic cells within the spleen controls prion neuroinvasionMarco Prinz, Mathias Heikenwalder, Tobias Junt, et al.Plos One|January 29, 2013
LIGHT/TNFSR14 can regulate hepatic lipase expression by hepatocytes independent of T cells and Kupffer cellsBijoy Chellan, Ekaterina P Koroleva, Timothy J Sontag, et al.Immunity|August 20, 2013
Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microfloraJu Qiu, Xiaohuan Guo, Zong-Ming E Chen, et al.JCI Insight|December 8, 2025
Anti-PD-L1-IFN-α-adjuvanted HBsAg vaccine overcomes HBV immune tolerance through targeting both DCs and macrophagesChao-Yang Meng, Yong Liang, Longxin Xu, et al.Pageof 34